BioCentury
ARTICLE | Clinical News

Mechlorethamine regulatory update

August 1, 2011 7:00 AM UTC

Yaupon submitted an NDA to FDA for a gel formulation of mechlorethamine to treat early stage mycosis fungoides, a type of cutaneous T cell lymphoma (CTCL). The topical form of nitrogen mustard, an alk...